SynthesisLancet (London, England)2015

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

J L Mega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.